Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Down-regulating Proteolysis to Enhance Anticancer Activity of Peptide Nanofibers.

Li J, Du X, Powell DJ, Zhou R, Shi J, He H, Feng Z, Xu B.

Chem Asian J. 2018 Nov 16;13(22):3464-3468. doi: 10.1002/asia.201800875. Epub 2018 Jul 24.

PMID:
29897657
2.

Depression in type 1 diabetes was associated with high levels of circulating galectin-3.

Melin EO, Dereke J, Thunander M, Hillman M.

Endocr Connect. 2018 Jun;7(6):819-828. doi: 10.1530/EC-18-0108. Epub 2018 May 14.

3.

Role of calcium-sensing receptor, Galectin-3, Cyclin D1, and Ki-67 immunohistochemistry to favor in the diagnosis of parathyroid carcinoma.

Sungu N, Dogan HT, Kiliçarslan A, Kiliç M, Polat S, Tokaç M, Akbaba S, Parlak Ö, Balci S, Ögüt B, Çakir B.

Indian J Pathol Microbiol. 2018 Jan-Mar;61(1):22-26. doi: 10.4103/IJPM.IJPM_85_17.

4.

Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects.

Vassalle C, Masotti S, Lubrano V, Basta G, Prontera C, Di Cecco P, Del Turco S, Sabatino L, Pingitore A.

Eur J Appl Physiol. 2018 Feb;118(2):411-417. doi: 10.1007/s00421-017-3783-x. Epub 2017 Dec 18.

PMID:
29256048
5.

Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study.

Ahmed RA, Shebl AM, Habashy HO.

Cancer Biol Med. 2017 Aug;14(3):319-326. doi: 10.20892/j.issn.2095-3941.2017.0024.

6.

Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Rebholz CM, Selvin E, Liang M, Ballantyne CM, Hoogeveen RC, Aguilar D, McEvoy JW, Grams ME, Coresh J.

Kidney Int. 2018 Jan;93(1):252-259. doi: 10.1016/j.kint.2017.06.028. Epub 2017 Aug 31.

PMID:
28865675
7.

A study of Galactin-3 on fine needle aspiration as a diagnostic marker differentiating benign from malignant thyroid neoplasm.

Muzafar A, Bukhari MH, Qureshi IU.

Pak J Med Sci. 2017 May-Jun;33(3):726-731. doi: 10.12669/pjms.333.12251.

8.

Galectin-3 in Children with Chronic Heart Failure with Normal and Reduced Ejection Fraction: Relationship to Disease Severity.

Kotby AA, Youssef OI, Elmaraghy MO, El Sharkawy OS.

Pediatr Cardiol. 2017 Jan;38(1):95-102. doi: 10.1007/s00246-016-1488-2. Epub 2016 Nov 11.

PMID:
27833993
9.

Exploration of early-life candidate biomarkers for childhood asthma using antibody arrays.

Xu H, Radabaugh T, Lu Z, Galligan M, Billheimer D, Vercelli D, Wright AL, Monks TJ, Halonen M, Lau SS.

Pediatr Allergy Immunol. 2016 Nov;27(7):696-701. doi: 10.1111/pai.12613. Epub 2016 Sep 12.

10.

Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy.

Abbas WA, Kasem Ahmed SM, Abdel Aal AM, Mahmoud AA, Abdelmalek MO, Mekky MA, Abozaid MA, Ibrahim AK.

Turk J Gastroenterol. 2016 Jul;27(4):367-74. doi: 10.5152/tjg.2016.16100.

11.

Identification of Lectins from Metastatic Cancer Cells through Magnetic Glyconanoparticles.

Kavunja HW, Voss PG, Wang JL, Huang X.

Isr J Chem. 2015 Mar 1;55(3-4):423-436. Epub 2015 Mar 23.

12.

Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium.

Fujii A, Shearer TR, Azuma M.

Exp Eye Res. 2015 Aug;137:71-8. doi: 10.1016/j.exer.2015.06.010. Epub 2015 Jun 10.

13.

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A.

Am J Hematol. 2015 Jun;90(6):524-8. doi: 10.1002/ajh.24001. Epub 2015 Apr 2.

14.

Unusual patterns of endometrial carcinoma including MELF and its relation to epithelial mesenchymal transition.

Zaino RJ.

Int J Gynecol Pathol. 2014 Jul;33(4):357-64. doi: 10.1097/PGP.0000000000000137. Review.

PMID:
24901395
15.

Annexin A7 and its binding protein galectin-3 influence mouse hepatocellular carcinoma cell line in vitro.

Song L, Mao J, Zhang J, Ibrahim MM, Li LH, Tang JW.

Biomed Pharmacother. 2014 Apr;68(3):377-84. doi: 10.1016/j.biopha.2013.10.011. Epub 2013 Dec 2.

PMID:
24373698
16.

Characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in Smad3(-/-) mice with dysregulated TGFβ.

Seamons A, Treuting PM, Brabb T, Maggio-Price L.

PLoS One. 2013 Nov 11;8(11):e79182. doi: 10.1371/journal.pone.0079182. eCollection 2013.

17.

Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.

Knapp JS, Lokeshwar SD, Vogel U, Hennenlotter J, Schwentner C, Kramer MW, Stenzl A, Merseburger AS.

World J Urol. 2013 Apr;31(2):351-8. doi: 10.1007/s00345-012-0925-y. Epub 2012 Aug 15.

PMID:
22892876
18.

Three cases of macrofollicular variant of papillary thyroid carcinoma.

Emad R, Maha A, Kfoury HK, Al-Sheikh AM, Zaidi SN.

Ann Saudi Med. 2011 Nov-Dec;31(6):644-7. doi: 10.4103/0256-4947.87104.

19.

Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.

Dancer JY, Truong LD, Zhai Q, Shen SS.

Arch Pathol Lab Med. 2010 Jan;134(1):90-4. doi: 10.1043/2008-0392-OAR1.1.

PMID:
20073610
20.

Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, Nakamura N, Scheithauer BW, Kovacs K, Lloyd RV.

Endocrine. 2006 Jun;29(3):435-44.

PMID:
16943582

Supplemental Content

Loading ...
Support Center